BIOLIT ApS: Financial statements 2025
CVR: 10068460
Source: annual report 2025, Danish Business Authority
01/06/2024 – 31/05/2025
BIOLIT ApS (CVR 10068460) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. That is an increase of 109.1% compared with the year before. Equity in the 2025 report amounted to DKK 10,762,624. The solvency ratio was 41.5%.
- Gross Profit
- DKK 125,902
- Profit/Loss
- DKK -20,616,619
- Equity
- DKK 10,762,624
- Total Assets
- DKK 25,927,187
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 126 t. | -20.6 mio. | 10.8 mio. | 0 |
| 2024 | - | 60 t. | 13 mio. | 31.4 mio. | 0 |
| 2023 | - | 974 t. | 4.8 mio. | 18.3 mio. | 0 |
| 2022 | - | 2.4 mio. | 3.2 mio. | 13.6 mio. | 0 |
| 2021 | - | 1.8 mio. | 1.6 mio. | 10.4 mio. | 0 |
Official annual report
How creditworthy is BIOLIT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BIOLIT ApS
BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees (2006). In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity in the 2025 report amounted to DKK 10,762,624.